Covered recipient · General Payments record
EDWARD SHIN
General Payments · PY2018–2024
$3,004.66
- Reported across 171 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $213.35 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $96.59 | 3 |
| Azurity Pharmaceuticals, Inc. | $35.93 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $27.97 | 1 |
| Lundbeck LLC | $22.29 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $16.26 | 1 |
| Hikma Pharmaceuticals USA | $14.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.83 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106088362 | CMS |
| ABBVIE INC. | $21.77 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106088364 | CMS |
| ABBVIE INC. | $49.99 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106088366 | CMS |
| Azurity Pharmaceuticals, Inc. | $16.22 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134012697 | CMS |
| Azurity Pharmaceuticals, Inc. | $19.71 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134012699 | CMS |
| Hikma Pharmaceuticals USA | $14.31 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127506087 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $16.26 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146794850 | CMS |
| Lundbeck LLC | $22.29 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145968902 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $27.97 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153633478 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.